Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital

Vaccine

Volumn 29, Issue 21, 2011, Pages 3767-3772

  Schluterman, Nicholas H ^a   Terplan, Mishka ^a   Lydecker, Alison D ^a   Tracy, J Kathleen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Cervical cancer; Electronic health record; Human papillomavirus (HPV) vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH INSURANCE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ATTITUDE TO HEALTH; CHILD; FEMALE; HEALTHCARE DISPARITIES; HOSPITALS, URBAN; HUMANS; INSURANCE, HEALTH; MULTIVARIATE ANALYSIS; ODDS RATIO; OUTPATIENTS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 79955115267     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.032     Document Type: Article

References (33)

1. American Cancer Society (ACS). Cervical cancer: key statistics; 2010. Available from: Accessed January 6, 2011. http://www.cancer.org/Cancer/CervicalCancer/DetailedGuide/cervical-cancer-key-statistics.
2. Downs L.S., Smith J.S., Scarinci I., Flowers L., Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 2008, 109(2 Suppl):S22-30.
3. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121(3):621-632.
4. Merck & Co. Highlights of prescribing information. Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant) suspension for intramuscular injection; 2009. Available at: Accessed September 19, 2010. http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf.
5. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007, 56:1-24.
6. Centers for Disease Control and Prevention (CDC) National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58:997-1001.
7. Centers for Disease Control and Prevention (CDC) National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:1018-1023.
8. Allen J.D., Mohllajee A.P., Shelton R.C., Othus M.K., Fontenot H.B., Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009, 48:420-425.
9. Crosby R., Schoenberg N., Hopenhayn C., Moore G., Melhan W. Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women. Sex Health 2007, 4:71-73.
10. Gerend M.A., Shepherd J.E. Using message framing to promote acceptance of the human papillomavirus vaccine. Health Psychol 2007, 26:745-752.
11. Gerend M.A., Shepherd J.E., Monday K.A. Behavioral frequency moderates the effects of message framing on HPV vaccine acceptability. Ann Behav Med 2008, 35:221-229.
12. Jones M., Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 2008, 57:23-32.
13. Licht A.S., Murphy J.M., Hyland A.J., Fix B.V., Hawk L.W., Mahoney M.C. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?. Sex Transm Infect 2010, 86:74-78.
14. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn St, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009, 18:1679-1686.
15. Gerend M.A., Lee S.C., Shepherd J.E. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007, 34:468-471.
16. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008, 111:1103-1110.
17. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey-adult 2007. Prev Med 2009, 48:426-431.
18. Pruitt S.L., Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med 2010, 38:525-533.
19. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99:1137-1142.
20. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009, 84:864-870.
21. Dempsey A., Cohn L., Dalton V., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28:989-995.
22. ICD-9 Code Book.
23. CPT Code Book.
24. United States Postal Service. ZIP Code Lookup. http://zip4.usps.com/zip4/welcome.jsp.
25. Food and Drug Administration. GARDASIL: full prescribing information; 2010. Available at: Accessed January 6, 2011. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm111263.pdf.
26. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008, 110:S4-S7.
27. Fazekas K.I., Brewer N.T., Smith J.S. HPV vaccine acceptability in a rural southern area. J Womens Health (Larchmt) 2008, 17:539-548.
28. Fang C.Y., Coups E.J., Heckman C.J. Behavioral correlates of HPV vaccine acceptability in the 2007 health information national trends survey (HINTS). Cancer Epidemiol Biomarkers Prev 2010, 19:319-326.
29. Constantine N.A., Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007, 40:108-115.
30. American Cancer Society. Human papillomavirus (HPV), cancer, and HPV vaccines-frequently asked questions; 2011. Available at: Accessed January 6, 2011. http://www.cancer.org/Cancer/CancerCauses/OtherCarcinogens/InfectiousAgents/HPV/HumanPapillomaVirusandHPVVaccinesFAQ/hpv-faq-vaccine-cost.
31. Centers for Disease Control and Prevention. Vaccines for children: for parents; 2010. Available at: Accessed January 6, 2011. http://www.cdc.gov.proxy-hs.researchport.umd.edu/vaccines/programs/vfc/parents/default.htm.
32. McCave E.L. Influential factors in HPV vaccination uptake among providers in four states. J Community Health 2010, 35:645-652.
33. Reiter P.L., Brewer N.T., Gottlieb S.L., McRee A.L., Smith J.S. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen. Vaccine 2009, 27:6840-6844.